Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effect of stress on brain inflammation and multiple sclerosis.
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
Drug expenditure of high-cost patients and their characteristics in Finland.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
[Microglia in pathophysiology of neuroimmunological disorders].
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Leukoencephalopathy due to Oral Methotrexate.
Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Aging and multiple sclerosis.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Fingolimod (Gilenya) eligibility extended by NHS England
Cost of disorders of the brain in Spain.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
Burden and quality of life in caregivers of persons with multiple sclerosis.
Pages
« first
‹ previous
…
317
318
319
320
321
322
323
324
325
…
next ›
last »